Medical/Pharmaceuticals
Everest Medicines and Providence Therapeutics announces that PTX-COVID19-B, a mRNA Vaccine for COVID-19, has received approval for inclusion in WHO Solidarity Trial Vaccines (STV) Program
SHANGHAI, Dec. 20, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) and Providence Therapeutics ("Providence") announced today that their COVID-19 vaccine, PTX-COVID19-B, has been recommended by an independent advisory group to be part of the WHO Solidarity Trial Vaccines ("STV") clinical t...
2021-12-20 20:55
5145
Thailand BOI Approves Extension of Investment Acceleration Package, EEC Incentive Package and Additional Special Zones
BANGKOK, Dec. 20, 2021 /PRNewswire/ -- The Thailand Board of Investment (BOI) at a meeting today approved a number of policy measures, namely an extension of the investment acceleration package and EEC incentive package, special incentive package for Yothi Medical Innovation Zone and classificati...
2021-12-20 20:49
4063
2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices
* Report developed as per Global Reporting Initiative (GRI) standards
* Extensively deals with the company's response to the Covid-19 pandemic
HYDERABAD, India, Dec. 20, 2021 /PRNewswire/ -- Sai Life Sciences, a leading
globalContract Research, Development & Manufacturing Organization
2021-12-20 19:16
1416
Syntach AB awarded an EU grant of € 2.5 million
LUND, Sweden, Dec. 20, 2021 /PRNewswire/ -- Syntach AB in Lund, Sweden has been awarded € 2.5 million as a grant and part of blended finance of up to € 17,5 million from the European Innovation Council (EIC) to support the development of its unique minimally invasive cardiac support system. Over...
2021-12-20 15:00
3264
First Patient Dosed in Australia in ATG-101 First-in-Human Trial
SHANGHAI and HONG KONG, Dec. 20, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...
2021-12-20 11:01
5030
First Patient Dosed in Australia in ATG-101 First-in-Human Trial
SHANGHAI AND HONG KONG, Dec. 19, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...
2021-12-20 10:56
3651
Japan's MHLW Approves Booster Shot for SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine
The SPIKEVAX® brand name was developed in partnership with Brand Institute, the global leader in pharmaceutical and healthcare-related name development MIAMI, Dec. 20, 2021 /PRNewswire/ -- Brand Institute is proud to announce its successful partnership with Moderna in naming their mRNA COVID-19 v...
2021-12-20 09:00
4962
Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine
* First EUL granted by WHO for a protein-based COVID-19 vaccine * EUL vaccine manufactured and marketed by SII as COVOVAX™ * WHO EUL for Nuvaxovid™ currently under assessment; will be completed following European Medicines Agency (EMA) review GAITHERSBURG, Md. and PUNE, India, Dec. 20, 2021 ...
2021-12-20 08:24
5661
Novo Nordisk among the top 3 Best Places to Work in Singapore for 2021
Singapore, Dec. 20, 2021 Novo Nordisk Singapore, an affiliate of the global healthcare company with more than 95 years of innovation and leadership in diabetes care, has recently been recognized among the top 3 Best Places to Work for 2021. During the assessment, the company received outsta...
2021-12-20 07:25
2589
Antengene Announces NDA Approval by NMPA for XPOVIO®, China's First XPO1 inhibitor, for the Treatment of Adults with Relapsed or Refractory Multiple Myeloma
SHANGHAI and HONG KONG, Dec. 17, 2021 /PRNewswire/ -- Antengene Corporation Limited (the "Company" or "Antengene") is pleased to announce thatATG-010 (selinexor, brand name:XPOVIO®), a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound has received conditional approval for...
2021-12-17 22:27
6328
Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Medulloblastoma
TAIPEI and SAN DIEGO, Dec. 17, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Des...
2021-12-17 20:00
3381
Westlake Omics Authorized as the Exclusive Distributor and Service Provider of Pressure BioSciences, Inc. in China
HANGZHOU, China, Dec. 17, 2021 /PRNewswire/ -- The Agreement signed by Westlake Omics (Hangzhou) Biotechnology Co., Ltd (hereinafter referred to as Westlake Omics) and Pressure BioSciences, Inc. (hereinafter referred to as PBI) on December 3, 2021 authorized Westlake Omics as the exclusive distrib...
2021-12-17 19:00
2437
Bioscience Animal Health Public Company Limited Accorded the International Innovation Awards 2021 for Angentex® COVID-19 qPCR Detection Kit
SINGAPORE, Dec. 17, 2021 /PRNewswire/ -- Enterprise Asia is pleased to honor 52 award recipients at the International Innovation Awards 2021. Spearheading the Innovation Revolution, the International Innovation Awards which aims to create an innovation ecosystem for enterprises is held annually t...
2021-12-17 18:24
2536
Study on Anti-aging with TCM Strides Forward
SHIJIAZHUANG, China, Dec. 17, 2021 /PRNewswire/ -- The opinions of experts on "Study on Anti-aging with Bazi Bushen Capsules Guided by Qi Collateral Theory" were released inShijiazhuang, Hebei on December 15. According to the opinions, the preliminary research of the project has created the theo...
2021-12-17 17:06
3676
Lipidor expands clinical program, announces investment in new drug development project against acne vulgaris
STOCKHOLM, Dec. 17, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North: LIPI) today announces that it has initiated a preclinical program for a new drug candidate, AKP-08, focused on acne vulgaris (acne). The market for acne medicines amounts to about35 billion SEK per year, which togethe...
2021-12-17 16:10
2894
"academist" and Sysmex R&D Center Europe to Begin Collaborating in Exploring and Nurturing "Research Seeds" in Europe
TOKYO, Dec. 17, 2021 /PRNewswire/ -- academist, Inc., which operates Japan's
first academic crowdfunding platform (https://academist-cf.com/?lang=en
2021-12-17 14:00
2518
Transcenta Announces the Appointment of Daniel Weng as CFO
SUZHOU, China, Dec. 17, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the appointment of Da...
2021-12-17 08:30
4889
Global Cord Blood Corporation Announces Rejection of Alternate Ocean Proposal
HONG KONG, Dec. 17, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its Board of Directors (the "...
2021-12-17 05:16
4473
Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia
* SAGE Healthcare Private Limited appointed to serve as a non-exclusive licensee and distributor for Volition's Nu.Q® Vet Cancer Screening Test in centralized labs inSingapore, with launch planned in Singapore in the first quarter of 2022 followed by expansion in conjunction with SAGE Healthcar...
2021-12-16 21:00
3771
Gracell Biotechnologies Selected for Addition to NASDAQ Biotechnology Index
SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Dec. 16, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment o...
2021-12-16 21:00
3412
Week's Top Stories
Most Reposted
Visa and Marina Bay Precinct Partners - Marina Bay Sands, UOB and Singapore Tourism Board - Present 'A Moment to Savour', Bringing International Restaurant Collaborations to Singapore
[Picked up by 309 media titles]
2026-10-27 13:40
HLB Customers Can Now Scan & Pay in China with HLB QR Pay
[Picked up by 297 media titles]
2026-10-22 22:35
Agoda becomes first travel platform regionally to seamlessly connect with Meta's Muse
[Picked up by 294 media titles]
2026-10-28 09:00
Hong Leong Bank Strengthens Cross-Border Payment Connectivity through Partnership with UnionPay International
[Picked up by 292 media titles]
2026-10-28 12:12
TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
[Picked up by 281 media titles]
2026-10-23 21:52
Most Read
Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
2026-10-23 23:30
39330
Home 3D Printers are More Accessible Than Ever This Black Friday with Bambu Lab
2026-10-22 17:00
39041
BeautyPlus Web Launches Halloween Photo Booth With Behind-the-Scenes Video Export
2026-10-23 01:00
38326
SwitchBot Launches AI Art Frame 2 with Full-Color E Ink and Personalized Art
2026-10-27 21:00
34031
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
31554